Insider · CIK 0001643653
Eric Benevich
directorofficer
Files at NBIX (NEUROCRINE BIOSCIENCES INC), ATYR (aTYR PHARMA INC). First filing Feb 4, 2025, latest Sep 10, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $1.8M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NBIX: NEUROCRINE BIOSCIENCES INC
NBIXOct 9, 2026 · close 142.44
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | NEUROCRINE BIOSCIENCES INC | $333k 2,154 shares | -3% | - | |
| 24Weak | NEUROCRINE BIOSCIENCES INC | $906k 5,970 shares | -12% | +74% from low-2% from high | |
| 8Weak | NEUROCRINE BIOSCIENCES INC | $251k 2,154 shares | -5% | - | |
| 5Weak | NEUROCRINE BIOSCIENCES INC | $116k 980 shares | -2% | - | |
| 7Weak | NEUROCRINE BIOSCIENCES INC | $185k 1,207 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Common Stock | +6,275 | $0.00 | $0 | 70,683 | 27 d ago |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -3,386 | $156.22 | $529k | 67,297 | 27 d ago |
| Sep 9, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +3,194 | $43.24 | $138k | 66,562 | 32 d ago |
| Sep 9, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -2,154 | $154.61 | $333k | 64,408 | 32 d ago |
| Sep 9, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Incentive Stock Optionderivative10b5-1 | -3,194 | $0.00 | $0 | 0 | 32 d ago |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +2,005 | $0.00 | $0 | 54,760 | Feb 17, 2026 |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -1,082 | $123.10 | $133k | 53,678 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +1,961 | $0.00 | $0 | 55,639 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -1,058 | $124.12 | $131k | 54,581 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +2,083 | $0.00 | $0 | 56,664 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -1,124 | $124.12 | $140k | 55,540 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Common Stock | +16,613 | $0.00 | $0 | 72,153 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -8,963 | $124.12 | $1.1M | 63,190 | Feb 17, 2026 |
| Feb 12, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative | -2,005 | $0.00 | $0 | 6,017 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative | -1,961 | $0.00 | $0 | 3,924 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative | -2,083 | $0.00 | $0 | 2,083 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Stock Optionderivative | +36,287 | $0.00 | $0 | 36,287 | Feb 17, 2026 |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Restricted Stock Unitderivative | +6,365 | $0.00 | $0 | 6,365 | Feb 17, 2026 |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock | +2,294 | $0.00 | $0 | 54,047 | Feb 3, 2026 |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | FTax withholding Common Stock | -1,292 | $136.06 | $176k | 52,755 | Feb 3, 2026 |
| Jan 31, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative | -2,294 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Nov 28, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +5,970 | $35.99 | $215k | 50,863 | Dec 2, 2025 |
| Nov 28, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -5,970 | $151.74 | $906k | 44,893 | Dec 2, 2025 |
| Nov 28, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Incentive Stock Optionderivative10b5-1 | -5,970 | $0.00 | $0 | 6,860 | Dec 2, 2025 |
| May 1, 2025 | ATYR aTYR PHARMA INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 2, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +2,083 | $0.00 | $0 | 44,882 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -1,098 | $116.74 | $128k | 43,784 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +1,961 | $0.00 | $0 | 45,745 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -1,056 | $116.71 | $123k | 44,689 | Feb 14, 2025 |
| Feb 12, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Stock Optionderivative10b5-1 | +42,805 | $0.00 | $0 | 42,805 | Feb 14, 2025 |
| Feb 12, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | AGrant or award Restricted Stock Unitderivative10b5-1 | +8,022 | $0.00 | $0 | 8,022 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,083 | $0.00 | $0 | 4,166 | Feb 14, 2025 |
| Feb 13, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,961 | $0.00 | $0 | 5,885 | Feb 14, 2025 |
| Feb 8, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +1,860 | $0.00 | $0 | 43,779 | Feb 12, 2025 |
| Feb 10, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -980 | $118.31 | $116k | 42,799 | Feb 12, 2025 |
| Feb 8, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,860 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Common Stock10b5-1 | +2,294 | $0.00 | $0 | 43,126 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | SOpen-market sale Common Stock10b5-1 | -1,207 | $152.94 | $185k | 41,919 | Feb 4, 2025 |
| Jan 31, 2025 | NBIX NEUROCRINE BIOSCIENCES INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -2,294 | $0.00 | $0 | 2,294 | Feb 4, 2025 |
| Dec 10, 2024 | ATYR aTYR PHARMA INC | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.